Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8141)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2015 (publication date) through May 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Suri A, Jagadish N, Saini S, Gupta N. Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challenges. World J Gastrointest Oncol 2015; 7(12): 492-502 [PMID: 26691579 DOI: 10.4251/wjgo.v7.i12.492] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v7/i12/492.htm |
| Number | Citing Articles |
| 1 |
Markus D. Lacher, Gerhard Bauer, Brian Fury, Sanne Graeve, Emily L. Fledderman, Tye D. Petrie, Dane P. Coleal-Bergum, Tia Hackett, Nicholas H. Perotti, Ying Y. Kong, William W. Kwok, Joseph P. Wagner, Charles L. Wiseman, William V. Williams. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00776
|
| 2 |
Olga Gordeeva. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy. Seminars in Cancer Biology 2018; 53: 75 doi: 10.1016/j.semcancer.2018.08.006
|
| 3 |
Alaa Alsalloum, Julia Shevchenko, Sergey Sennikov. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?. Cancers 2023; 15(6): 1779 doi: 10.3390/cancers15061779
|
| 4 |
Rui Bai, Cheng Yuan. Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen. Aging and disease 2022; 13(4): 1267 doi: 10.14336/AD.2021.1207
|
| 5 |
Guangyuan Li, Daniel Schnell, Anukana Bhattacharjee, Mark Yarmarkovich, Nathan Salomonis. Quantifying tumor specificity using Bayesian probabilistic modeling for drug and immunotherapeutic target discovery. Cell Reports Methods 2024; 4(11): 100900 doi: 10.1016/j.crmeth.2024.100900
|
| 6 |
Ye-Rin Kim, Myung-Ha Song, Jun-Won Lee, Jae-Ho Bae, Jong-Eun Kim, Dong-Muk Kang, Sang-Yull Lee. Identification of tumor antigens in malignant mesothelioma. Oncology Letters 2017; 14(4): 4557 doi: 10.3892/ol.2017.6805
|
| 7 |
Rongrong Luo, Xiying Li, Ruyun Gao, Mengwei Yang, Juan Cai, Liyuan Dai, Nin Lou, Guangyu Fan, Haohua Zhu, Shasha Wang, Zhishang Zhang, Le Tang, Jiarui Yao, Di Wu, Yuankai Shi, Xiaohong Han, Heng Zhu. A Novel IgG–IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules. Genomics, Proteomics & Bioinformatics 2025; 22(6) doi: 10.1093/gpbjnl/qzae085
|
| 8 |
Zhongen Wu, Mengxuan Yang, Yiou Cao. Tumor antigens and vaccines in colorectal cancer. Medicine in Drug Discovery 2022; 16: 100144 doi: 10.1016/j.medidd.2022.100144
|
| 9 |
Ragaa A Ramadan, Heba Morsy, Mohamed Samir, Mohamed Shamseya, Maha Shalaby, Eman A El-Attar. Significance of cancer testis-associated antigens (SPAG9 and FBXO39) in colon cancer. Indian Journal of Cancer 2022; 59(3): 394 doi: 10.4103/ijc.IJC_873_19
|
| 10 |
Erik Schooten, Alessia Di Maggio, Paul M.P. van Bergen en Henegouwen, Marta M. Kijanka. MAGE-A antigens as targets for cancer immunotherapy. Cancer Treatment Reviews 2018; 67: 54 doi: 10.1016/j.ctrv.2018.04.009
|
| 11 |
Mikhlid H. Almutairi, Mona M. Alotaibi, Rasha Alonaizan, Bader O. Almutairi, Hafiz Ishfaq Ahmad. [Retracted] Expression Profile of MAGE‐B1 Gene and Its Hypomethylation Activation in Colon Cancer. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/6066567
|
| 12 |
Ping Yang, Mei Meng, Quansheng Zhou. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(1): 188558 doi: 10.1016/j.bbcan.2021.188558
|
| 13 |
Mei Feng, Zhongwei Zhao, Mengxuan Yang, Jiansong Ji, Di Zhu. T-cell-based immunotherapy in colorectal cancer. Cancer Letters 2021; 498: 201 doi: 10.1016/j.canlet.2020.10.040
|
| 14 |
Ana Roguljic, Gulio Spagnoli, Antonio Juretic, Bozena Sarcevic, Marija Banovic, Lidija Beketic Oreskovic. Possible predictive role of cancer/testis antigens in breast ductal carcinoma in�situ. Oncology Letters 2018; doi: 10.3892/ol.2018.9544
|
| 15 |
Mikhlid H. Almutairi, Turki M. Alrubie, Abdullah M. Alamri, Bader O. Almutairi, Abdulwahed F. Alrefaei, Maha M. Arafah, Mohammad Alanazi, Abdelhabib Semlali. Cancer-Testis Gene Biomarkers Discovered in Colon Cancer Patients. Genes 2022; 13(5): 807 doi: 10.3390/genes13050807
|